Eventide Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-255,407
| Closed | -$6.17M | – | 255 |
|
|
2025
Q1 | $6.17M | Sell |
255,407
-187,290
| -42% | -$4.52M | 0.12% | 136 |
|
|
2024
Q4 | $17.8M | Sell |
442,697
-10,272
| -2% | -$413K | 0.32% | 98 |
|
|
2024
Q3 | $28.7M | Buy |
452,969
+200,000
| +79% | +$12.7M | 0.49% | 66 |
|
|
2024
Q2 | $13.4M | Hold |
252,969
| – | – | 0.23% | 113 |
|
|
2024
Q1 | $20.7M | Sell |
252,969
-497,031
| -66% | -$40.8M | 0.33% | 91 |
|
|
2023
Q4 | $14M | Hold |
750,000
| – | – | 0.23% | 107 |
|
|
2023
Q3 | $8.3M | Hold |
750,000
| – | – | 0.15% | 128 |
|
|
2023
Q2 | $12.2M | Buy |
+750,000
| New | +$12.2M | 0.21% | 116 |
|
|
2019
Q2 | – | Sell |
-1,757,000
| Closed | -$17.5M | – | 127 |
|
|
2019
Q1 | $17.5M | Hold |
1,757,000
| – | – | 0.6% | 63 |
|
|
2018
Q4 | $13.4M | Buy |
1,757,000
+967,000
| +122% | +$7.4M | 0.6% | 58 |
|
|
2018
Q3 | $13.8M | Buy |
+790,000
| New | +$13.8M | 0.51% | 65 |
|